Detection and Characteristics of Rifampicin-Resistant Isolates of Mycobacterium tuberculosis

被引:2
|
作者
Cherednichenko, A. G. [1 ]
Dymova, M. A. [2 ,3 ]
Solodilova, O. A. [4 ]
Petrenko, T. I. [1 ]
Prozorov, A. I. [4 ]
Filipenko, M. L. [2 ,3 ]
机构
[1] Minist Hlth Russian Federat, Res Inst TB, Novosibirsk, Russia
[2] Russian Acad Sci, Siberian Div, Inst Chem Biol & Fundamental Med, Novosibirsk, Russia
[3] Novosibirsk State Univ, Novosibirsk 630090, Russia
[4] Altai Reg AntiTB Dispensary, Barnaul, Russia
关键词
Mycobacterium tuberculosis; drug resistance; rifampicin; rpoB gene;
D O I
10.1007/s10517-016-3243-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Genotyping and analysis the drug resistance of 59 isolates of M. tuberculosis obtained from patients living in Altai Territory were performed using a BACTEC MGIT 960 fluorometric system by means of VNTR typing (variable number tandem repeat), PCR-RFLP analysis, and sequence analysis. The occurrence frequency was highest for isolates of the Beijing family (n=30, 50.8%). Analysis of mutation spectrum in the rpoB gene associated with rifampicin resistance revealed the major mutation (codon 531 of the rpoB gene) in 93% samples, which allows us to use rapid test systems.
引用
收藏
页码:659 / 663
页数:5
相关论文
共 50 条
  • [22] Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
    Zehua Zhang
    Fei Dai
    Fei Luo
    Min Zhong
    Zhenggu Huang
    Tianyong Hou
    Jianzhong Xu
    Journal of Orthopaedic Surgery and Research, 9
  • [23] Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
    Zhang, Zehua
    Dai, Fei
    Luo, Fei
    Zhong, Min
    Huang, Zhenggu
    Hou, Tianyong
    Xu, Jianzhong
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2014, 9 : 124
  • [24] Profiling and identification of novel rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis clinical isolates from Pakistan
    Qadir, Mehmood
    Tahseen, Sabira
    McHugh, Timothy D.
    Hussain, Alamdar
    Masood, Faisal
    Ahmed, Niaz
    Faryal, Rani
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (11) : 1578 - 1583
  • [25] Second-line drug susceptibilities of multidrug- and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi
    Sidiq, Zeeshan
    Hanif, M.
    Chopra, K. K.
    Khanna, Ashwani
    Jadhav, Indrani
    Dwivedi, Kaushal Kumar
    BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2019, 3 (02): : 87 - 91
  • [26] In-vitro activity of rifabutin against rifampicin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
    Cavusoglu, C
    Karaca-Derici, Y
    Bilgic, A
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) : 662 - 665
  • [27] Study of rifampicin and silver nanoparticle composite efficacy on rifampicin-resistant Mycobacterium tuberculosis strains
    Kiria, N.
    Avaliani, T.
    Bablishvili, N.
    Kiria, N.
    Phichkhaia, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [28] Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid
    Benaissa, E.
    Benlahlou, Y.
    Bssaibis, F.
    Maleb, A.
    Elouennass, M.
    CLINICAL LABORATORY, 2022, 68 (03) : 532 - 538
  • [29] Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid
    Cacho-Calvo, Juana
    Martin-Diaz, Ariadna
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (07): : 486 - 487
  • [30] Comprehensive identification of compensatory mutations in rifampicin-resistant Mycobacterium tuberculosis strains
    左天宇
    China Medical Abstracts(Internal Medicine), 2018, 35 (02) : 98 - 99